WEST CHESTER, Pa., Oct. 14, 2025 /PRNewswire/ -- Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced U.S. Food and Drug Administration … [Read more...] about Centinel Spine® Receives Two-Level FDA Approval for prodisc® C Vivo and prodisc® C SK Match-the-Disc™ Cervical Total Disc Replacement Devices
NEWS
SMAIO Announces Strong First-Half 2025 Results and Robust Growth in Business Activity in the Third Quarter of 2025
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker : ALSMA), a French-American player specialized in complex spine surgery with a global offer comprising software, adaptative implants and related services, today publishes its consolidated results for the first half of 20251 and its … [Read more...] about SMAIO Announces Strong First-Half 2025 Results and Robust Growth in Business Activity in the Third Quarter of 2025
Johnson & Johnson Follows in Zimmer Biomet’s Footsteps: An Analysis of the DePuy Synthes Spin-Off Compared to ZimVie
Johnson & Johnson (J&J) announced today its plan to spin off its orthopaedics business, which will operate as an independent company under the name DePuy Synthes. This move echoes a similar strategy by Zimmer Biomet in 2022, when it separated its spine and dental units to form ZimVie. Both cases highlight a growing trend in the MedTech sector: streamlining conglomerates … [Read more...] about Johnson & Johnson Follows in Zimmer Biomet’s Footsteps: An Analysis of the DePuy Synthes Spin-Off Compared to ZimVie
Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
Strengthens focus of Johnson & Johnson as an innovation powerhouse and accelerates the portfolio shift of its MedTech Segment to higher-growth and higher-margin markets Standalone orthopaedics business would operate as DePuy Synthes and be the largest, most comprehensive orthopaedics-focused company in the world Namal Nawana appointed to serve as Worldwide … [Read more...] about Johnson & Johnson Announces Intent to Separate Its Orthopaedics Business
From Early Innovations to Modern Practice: Where Are Dynamic and Semi-Rigid Spine Systems Today?
Following the recent publication this week of the MDR for the BDyn dynamic rod, I felt it was timely to revisit a topic that had a significant impact in the early 2000s, when dynamic stabilization systems experienced a major surge in interest and adoption. This development reminds us of the clinical and technological debates surrounding motion-preserving spinal implants, … [Read more...] about From Early Innovations to Modern Practice: Where Are Dynamic and Semi-Rigid Spine Systems Today?
Next-Generation AI-Driven SyncAR® Spine Receives FDA Clearance for Spine Surgery
By bringing MRI and CT directly into the operating room, SyncAR Spine turns preoperative planning imaging into real-time intraoperative guidance. CLEVELAND, Oct. 10, 2025 /PRNewswire/ -- Surgical Theater, the leader in surgical XR visualization, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for SyncAR® Spine, the next-generation … [Read more...] about Next-Generation AI-Driven SyncAR® Spine Receives FDA Clearance for Spine Surgery
BDyn Posterior Dynamic Stabilization System Earns MDR Certification!
Cousin Surgery is proud to announce a major milestone: BDyn Posterior Dynamic Stabilization System has officially received MDR (Medical Device Regulation – EU 2017/745) certification! This achievement marks an important step forward in our ongoing commitment to the highest European standards of safety, quality, and performance for medical devices. Raising the bar for … [Read more...] about BDyn Posterior Dynamic Stabilization System Earns MDR Certification!
SpineGuard reports its Q3 2025 revenue
PARIS and BOULDER (CO), October 9, 2025 – 6:00 pm CEST - SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces its third quarter 2025 revenue. Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, … [Read more...] about SpineGuard reports its Q3 2025 revenue
Largest Real-World Study Confirms Long-Term Safety and Efficacy of Minimally Invasive Posterior SI Joint Fusion Using Novel Cortical Allograft
TAMPA, Fla., Oct. 8, 2025 /PRNewswire/ -- A new multi-center U.S. study, recently published in Orthopedic Research and Reviews, confirms that posterior sacroiliac (SI) joint fusion with a cortical allograft implant, LINQ® delivers significant, sustained pain relief for patients with chronic SI joint dysfunction. The retrospective study evaluated … [Read more...] about Largest Real-World Study Confirms Long-Term Safety and Efficacy of Minimally Invasive Posterior SI Joint Fusion Using Novel Cortical Allograft
IMPLANET Reports Q3 2025 Revenue of €2.9 Million, Up +26%
BORDEAUX, France & BOSTON--Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), a medical technology company specializing in implants for orthopedic surgery and the distribution of advanced medical equipment, today announced its revenue for the third quarter of 2025, ended September 30, 2025, as well as its revenue for the first nine … [Read more...] about IMPLANET Reports Q3 2025 Revenue of €2.9 Million, Up +26%
Smart Implants, Connected Care: The Next Generation of Spine Implants?
For years, spinal implants have been passive structures—titanium or polymer components designed to stabilize, fuse, or correct anatomy. However, a new generation of smart implants is transforming this landscape. Equipped with sensors, microchips, and wireless connectivity, these devices promise something that was once impossible: a real-time window into the patient’s … [Read more...] about Smart Implants, Connected Care: The Next Generation of Spine Implants?
RevBio Receives a $2.2 Million Phase II NIH Grant to Further Develop the Minimally Invasive Use of TETRANITE® to Treat Complex Spine Fractures
LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it has been awarded a $2.2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). This two-year grant (1R44AG097243-01) builds upon the work that was completed in a prior Phase I grant (1R43AG079741-01A1) and will … [Read more...] about RevBio Receives a $2.2 Million Phase II NIH Grant to Further Develop the Minimally Invasive Use of TETRANITE® to Treat Complex Spine Fractures
Spineart Raises CHF 25M to Boost Global Expansion and Spine Surgery Innovation
Geneva, October 1, 2025. Swiss medtech company Spineart has secured a CHF 25 million investment to accelerate its international growth and bring new technologies to the spine surgery market. The round was supported by long-term partners Gimv and EGS Beteiligungen (EGSB), reaffirming investor confidence in the company’s trajectory.The fresh funding will enable Spineart to scale … [Read more...] about Spineart Raises CHF 25M to Boost Global Expansion and Spine Surgery Innovation
Scrub Capital Invests in Spark Spine to Accelerate Innovation in Regenerative Medical Devices
New biomaterial "EMP" adds electricity to orthopedic implants BOSTON, MA, UNITED STATES, October 2, 2025 /EINPresswire.com/ -- Scrub Capital, a venture capital firm focused on early-stage healthtech and life sciences innovation, is proud to announce its investment in Spark Spine, a pioneering medical device company developing next-generation technologies to accelerate … [Read more...] about Scrub Capital Invests in Spark Spine to Accelerate Innovation in Regenerative Medical Devices
ChoiceSpine™ Announces Line Extension of TigerShark™ Lateral Interbody System
KNOXVILLE, Tenn.--(BUSINESS WIRE)--ChoiceSpine LLC, a provider of differentiated spine surgery systems proudly announces the launch of a significant line extension for their TigerShark Lateral Interbody System. Developed in close collaboration with Stuart D. Kinsella, MD, MSTR of The Steadman Clinic, the expanded implant offering is designed to accommodate a broader range of … [Read more...] about ChoiceSpine™ Announces Line Extension of TigerShark™ Lateral Interbody System
Synergy Spine Solutions and Johnson & Johnson MedTech Extend Strategic Collaboration into Germany
Louisville, Colorado – October 1 – Synergy Spine Solutions, an innovative orthopaedic medical device company focused on artificial cervical disc replacement, today announced the expansion of its sales agency agreement with Johnson & Johnson MedTech Germany. This agreement builds on the success of the existing sales agency agreements with Johnson & Johnson Medtech … [Read more...] about Synergy Spine Solutions and Johnson & Johnson MedTech Extend Strategic Collaboration into Germany
Spineart and Biobank announce Strategic Partnership for spine surgery in France and Switzerland
BIOBank, a French leader in bone allografts, and Spineart are proud to announce a strategic partnership aimed at improving access to high-quality allogenic bone substitutes for spine surgeons in France and Switzerland. A Synergistic Approach to Spinal Fusion Under the agreement, Spineart will promote BIOBank’s portfolio, with a focus on BIOBank Synergy® – a moldable … [Read more...] about Spineart and Biobank announce Strategic Partnership for spine surgery in France and Switzerland
Vivex Biologics Treats First Patient in its Restore Trial Evaluating VIA Disc NP™ for Patients with Degenerative Disc Disease
MIAMI, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, a leader in developing and delivering innovative allografts, today announced that it has treated the first patient in its Restore U.S. clinical trial evaluating VIA Disc NP™ for patients with lumbar discogenic pain associated with degenerative disc disease (DDD). “We are proud to advance the clinical evaluation of … [Read more...] about Vivex Biologics Treats First Patient in its Restore Trial Evaluating VIA Disc NP™ for Patients with Degenerative Disc Disease
Why MedTech Investors Must Heed: Dr. Kingsley R. Chin’s Historic Keynote in South Korea Spotlights the Next Wave of Spine Innovations
FORT LAUDERDALE, Fla., Sept. 30, 2025 /PRNewswire/ -- As the spine industry today continues to double down on rigid fixation and hospital-driven procedures, orthopedic spine surgeon, professor, and KIC Ventures CEO & Founder Dr. Kingsley R. Chin stands out for having charted a different course years earlier. In his 2018 keynote at the 32nd Annual Meeting of the Korean … [Read more...] about Why MedTech Investors Must Heed: Dr. Kingsley R. Chin’s Historic Keynote in South Korea Spotlights the Next Wave of Spine Innovations